INGELHEIM, Germany - Thursday, February 21st 2013 [ME NewsWire]

    Pradaxa® (dabigatran etexilate) reduced the risk of recurrent deep vein thrombosis (DVT) or pulmonary embolism (PE) by an impressive 92% vs. placebo1
    Patients receiving Pradaxa® had a 46% lower risk of clinically relevant bleeding (including major bleeding) vs. warfarin in long-term prevention of up to 3 years1
    Pradaxa® is the only novel oral anticoagulant which in its clinical trials vs. warfarin has shown lower rates of clinically relevant bleeding (including major bleeding) in patients with either DVT or PE.1,2,3

(BUSINESS WIRE)-- For Non-US, Non-UK & Non-Canadian Media Only

Today, theNew England Journal of Medicine published findings from the RE-MEDYTM and RE-SONATETM trials investigating Pradaxa® (dabigatran etexilate) in the long-term prevention of deep vein thrombosis (DVT) or pulmonary embolism (PE). The results ... Read more »

Executives Look to Africa for Expansion in 2013

BRUSSELS - Thursday, February 21st 2013 [ME NewsWire]

• Executives Split on Their Ability to Access Capital or Credit in 2013
• ... Read more »

BAD BIRNBACH, Germany - Thursday, February 21st 2013 [BUSINESS WIRE/ ME NewsWire]

FotoFinder, manufacturer of medical imaging solutions, announces the launch of its mobile dermatoscope, handyscope® for iPhone 5. handyscope® will debut in the United States at the Annual Meeting of the American Academy of Dermatology in Miami, March 1-5, 2013. This new handyscope® model enables doctors to better examine a mole through a new twin-light system and various new features.

The new handyscope® for iPhone 5 features a slim design and a unique twin-light mode that combines the advantages of cross-polarized and immersion fluid dermoscopy. A quick tap button provides for toggling between both modes and a LED indicates the chosen light option.

The new model enables doctors to take pictures with or without glass contact with the skin. Two front pieces – one with a glass contact plate and one without – allow doctors to view elevated lesions and vascular conditions ... Read more »

NUREMBERG, Germany - Thursday, February 21st 2013 [ME NewsWire]

(BUSINESS WIRE)-- GfK has integrated EMO Scan, its award-winning biometric measure of emotional response, into its market-validated ad testing system. Available globally, EMO Scan gains consumers’ permission to use their own webcams, to track their facial movement in real time as they view advertising.

"Our system is unique because it reads peoples’ authentic emotional response to advertising using an exposure environment that is not forced” says Nathalie Mandavit, Global Director of GfK Communication Efficiency. "A low involvement viewing experience is absolutely essential, to capture people’s spontaneous reactions to the advertising creative, unaffected by influences from an artificial environment. This means that we can deliver outstanding sensitivity in our measure of emotional response – which, when fully integrated with a person’s claimed emotions towards an ad, significantly boosts our clients’ success ... Read more »

VISIBILITY Iliac and DURABILITY Iliac Studies Evaluate the Safety and Effectiveness of Balloon Expandable and Self-Expanding Stents in Treating Iliac Artery Disease

MANSFIELD, Mass. - Wednesday, February 20th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the completion of patient enrollment in its iliac stent clinical study series. The series is composed of two prospective, multinational, multicenter studies - VISIBILITY Iliac and DURABILITY Iliac.

Each study is designed to evaluate the safety and effectiveness of using either balloon expandable or self-expanding stents to treat peripheral arterial disease (PAD) in the common iliac and external iliac arteries.Located in the lower abdomen, the common iliac and external iliac arteries are the main conduits delivering blood to the arteries in the legs.

According to the American Heart Association, approximately eight million people i ... Read more »

Smaller, thinner package contributes to saving board space

ME Newswire / Business Wire

TOKYO - Wednesday, February 20th 2013

Toshiba Corporation(TOKYO:6502) today announced that it has launched a photo transistor coupler for factory automation devices and air-conditioners that guarantees high temperature operation (Ta = 110°C max.) and high collector voltage (VCEO) of 350V.

The new product, "TLP188", guarantees minimum creepage and clearance distance of 5mm, and can be used at up to 707 Vpk of maximum permissible operating isolation voltage, as specified in the EN 60747-5-5 safety standard. With a guaranteed internal insulation thickness of 0.4mm, TLP188 fully conforms with the reinforced insulation category of various safety standards.

TLP188 can replace the current Toshiba product, "TLP628 (DIP4 package)", and can contribute to saving board space through its use of the smaller, thinner SO6 package.

Applications Factory Automation (FA) device ... Read more »

FOSTER CITY, Calif. - Wednesday, February 20th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Synactive, Inc., (www.guixt.com) today announced the availability of GuiXT® Liquid UI™ Client for SAP which connects to SAP® ERP through patented connectivity technology enabling users to access native SAP transactions. The app, now available through the App Store, requires no additional infrastructure for users to experience SAP GUI re-designed and re-imagined for iPads, iPhones and iPod touch devices.

Synactive also announced the Liquid UI Platform that enables new mobile applications to be built on top of existing SAP transaction logic through a innovative "record once, run everywhere” technology, without Java or ABAP programming. A single script can create front-end changes to SAP GUI, scan guns, web browser and smartphones/tablets. "Just start from any SAP ERP module and build upon it,” said DeeDee Kato, Director of Marketing at Synactive. "Liquid UI connects to SAP ERP via hi ... Read more »

Acquisition Expands TSYS’ Role in High-Growth Area of Payments


COLUMBUS, Ga. & AUSTIN, Texas - Wednesday, February 20th 2013 [ME NewsWire]

(BUSINESS WIRE)-- TSYS® (NYSE: TSS), a leading global payment solutions provider, and NetSpend (NASDAQ: NTSP), a leading provider of general purpose reloadable (GPR) prepaid debit cards and related financial services to underbanked consumers in the United States, today announced that they have entered into a definitive agreement pursuant to which TSYS will acquire NetSpend in an all cash transaction valued at approximately $1.4 billion. Under terms of the agreement, NetSpend shareholders will receive $16.00 in cash for each share of NetSpend common stock. TSYS expects the transaction to be accretive to GAAP EPS for the first 12 month period following closing, excluding one-time acquisition related fees and expenses.

NetSpend’s extensive distribution network provides consumers the ability to purchase prepaid debit ca ... Read more »